A candidate molecular signature associated with tamoxifen failure in primary breast cancer

INTRODUCTION: Few markers are available that can predict response to tamoxifen treatment in estrogen receptor (ER)-positive breast cancers. Identification of such markers would be clinically useful. We attempted to identify molecular markers associated with tamoxifen failure in breast cancer. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Vendrell, Julie A, Robertson, Katherine E, Ravel, Patrice, Bray, Susan E, Bajard, Agathe, Purdie, Colin A, Nguyen, Catherine, Hadad, Sirwan M, Bieche, Ivan, Chabaud, Sylvie, Bachelot, Thomas, Thompson, Alastair M, Cohen, Pascale A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614524/
https://www.ncbi.nlm.nih.gov/pubmed/18928543
http://dx.doi.org/10.1186/bcr2158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614524/
https://www.ncbi.nlm.nih.gov/pubmed/18928543
http://dx.doi.org/10.1186/bcr2158

Ejemplares similares